Author Correction: Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations.
作者信息
Huang Jane J, Channa Roomasa, Wolf Risa M, Dong Yiwen, Liang Mavis, Wang Jiangxia, Abramoff Michael D, Liu T Y Alvin
机构信息
Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
出版信息
NPJ Digit Med. 2024 Aug 23;7(1):220. doi: 10.1038/s41746-024-01229-y.
Abstract
摘要
相似文献
1
Author Correction: Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations.作者更正：用于糖尿病眼病的自主人工智能增加了服务不足人群的医疗可及性和健康公平性。
NPJ Digit Med. 2024 Aug 23;7(1):220. doi: 10.1038/s41746-024-01229-y.
2
Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes.自主人工智能增加了糖尿病患者中弱势群体的医疗服务可及性和健康公平性。
Res Sq. 2024 Mar 13:rs.3.rs-3979992. doi: 10.21203/rs.3.rs-3979992/v1.
3
Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations.用于糖尿病眼病的自主人工智能增加了服务不足人群获得医疗服务的机会和健康公平性。
NPJ Digit Med. 2024 Jul 22;7(1):196. doi: 10.1038/s41746-024-01197-3.
4
Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial.自主人工智能增加青少年糖尿病视网膜病变的筛查和随访：ACCESS 随机对照试验。
Nat Commun. 2024 Jan 11;15(1):421. doi: 10.1038/s41467-023-44676-z.
5
The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth.SEE 研究：在青少年糖尿病视网膜病变诊断中实施自主人工智能的安全性、有效性和公平性。
Diabetes Care. 2021 Mar;44(3):781-787. doi: 10.2337/dc20-1671. Epub 2021 Jan 21.
6
Determinants for scalable adoption of autonomous AI in the detection of diabetic eye disease in diverse practice types: key best practices learned through collection of real-world data.在不同实践类型中可扩展采用自主人工智能检测糖尿病眼病的决定因素：通过收集真实世界数据学到的关键最佳实践。
Front Digit Health. 2023 May 18;5:1004130. doi: 10.3389/fdgth.2023.1004130. eCollection 2023.
7
Autonomous Artificial Intelligence in Diabetic Retinopathy: From Algorithm to Clinical Application.糖尿病视网膜病变的自主人工智能：从算法到临床应用。
J Diabetes Sci Technol. 2021 May;15(3):695-698. doi: 10.1177/1932296820909900. Epub 2020 Mar 4.
8
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.自主检测可转诊和威胁视力的糖尿病视网膜病变的人工智能系统的关键性评估。
JAMA Netw Open. 2021 Nov 1;4(11):e2134254. doi: 10.1001/jamanetworkopen.2021.34254.
9
Performance of an artificial intelligence automated system for diabetic eye screening in a large English population.人工智能自动化系统在英语人群中进行糖尿病眼病筛查的性能。
Diabet Med. 2023 Jun;40(6):e15055. doi: 10.1111/dme.15055. Epub 2023 Mar 2.
10
Validation of Automated Screening for Referable Diabetic Retinopathy With an Autonomous Diagnostic Artificial Intelligence System in a Spanish Population.利用自主诊断人工智能系统对西班牙人群进行可转诊糖尿病视网膜病变的自动筛查验证。
J Diabetes Sci Technol. 2021 May;15(3):655-663. doi: 10.1177/1932296820906212. Epub 2020 Mar 16.
引用本文的文献
1
Cost-effectiveness of AI for pediatric diabetic eye exams from a health system perspective.从卫生系统角度看人工智能用于儿科糖尿病眼部检查的成本效益
NPJ Digit Med. 2025 Jan 2;8(1):3. doi: 10.1038/s41746-024-01382-4.
Zotero 插件